GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Beximco Pharmaceuticals Ltd (LSE:BXP) » Definitions » Cyclically Adjusted PB Ratio

Beximco Pharmaceuticals (LSE:BXP) Cyclically Adjusted PB Ratio : 1.43 (As of Jun. 09, 2024)


View and export this data going back to 2005. Start your Free Trial

What is Beximco Pharmaceuticals Cyclically Adjusted PB Ratio?

As of today (2024-06-09), Beximco Pharmaceuticals's current share price is £0.385. Beximco Pharmaceuticals's Cyclically Adjusted Book per Share for the quarter that ended in Mar. 2024 was £0.27. Beximco Pharmaceuticals's Cyclically Adjusted PB Ratio for today is 1.43.

The historical rank and industry rank for Beximco Pharmaceuticals's Cyclically Adjusted PB Ratio or its related term are showing as below:

LSE:BXP' s Cyclically Adjusted PB Ratio Range Over the Past 10 Years
Min: 0.58   Med: 1.87   Max: 3.03
Current: 1.32

During the past years, Beximco Pharmaceuticals's highest Cyclically Adjusted PB Ratio was 3.03. The lowest was 0.58. And the median was 1.87.

LSE:BXP's Cyclically Adjusted PB Ratio is ranked better than
63.88% of 742 companies
in the Drug Manufacturers industry
Industry Median: 1.875 vs LSE:BXP: 1.32

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PB Ratio. The Cyclically Adjusted Book per Share is the average of the inflation adjusted book value per share of a company over the past 10 years.

Beximco Pharmaceuticals's adjusted book value per share data for the three months ended in Mar. 2024 was £0.697. Add all the adjusted book value per share for the past 10 years together and divide the count will get our Cyclically Adjusted Book per Share, which is £0.27 for the trailing ten years ended in Mar. 2024.

Shiller PE for Stocks: The True Measure of Stock Valuation


Beximco Pharmaceuticals Cyclically Adjusted PB Ratio Historical Data

The historical data trend for Beximco Pharmaceuticals's Cyclically Adjusted PB Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Beximco Pharmaceuticals Cyclically Adjusted PB Ratio Chart

Beximco Pharmaceuticals Annual Data
Trend Dec13 Dec14 Dec15 Jun17 Jun18 Jun19 Jun20 Jun21 Jun22 Jun23
Cyclically Adjusted PB Ratio
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.78 0.69 2.10 2.01 1.91

Beximco Pharmaceuticals Quarterly Data
Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Dec23 Mar24
Cyclically Adjusted PB Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 1.87 1.96 1.91 1.87 1.44

Competitive Comparison of Beximco Pharmaceuticals's Cyclically Adjusted PB Ratio

For the Drug Manufacturers - Specialty & Generic subindustry, Beximco Pharmaceuticals's Cyclically Adjusted PB Ratio, along with its competitors' market caps and Cyclically Adjusted PB Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Beximco Pharmaceuticals's Cyclically Adjusted PB Ratio Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Beximco Pharmaceuticals's Cyclically Adjusted PB Ratio distribution charts can be found below:

* The bar in red indicates where Beximco Pharmaceuticals's Cyclically Adjusted PB Ratio falls into.



Beximco Pharmaceuticals Cyclically Adjusted PB Ratio Calculation

Like the Shiller PE Ratio, the Cyclically Adjusted PB Ratio takes the Book Value per Share from the past 10 years, adjusts it for inflation, and then calculates the average. This average is then used for the P/B calculation. Because it considers this 10-year average, it's often referred to as the CAPB Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller to measure the valuation of the overall market. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PB Ratio.

Beximco Pharmaceuticals's Cyclically Adjusted PB Ratio for today is calculated as

Cyclically Adjusted PB Ratio=Share Price/ Cyclically Adjusted Book per Share
=0.385/0.27
=1.43

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Beximco Pharmaceuticals's Cyclically Adjusted Book per Share for the quarter that ended in Mar. 2024 is calculated as:

For example, Beximco Pharmaceuticals's adjusted Book Value per Share data for the three months ended in Mar. 2024 was:

Adj_Book=Book Value per Share/CPI of Mar. 2024 (Change)*Current CPI (Mar. 2024)
=0.697/131.7762*131.7762
=0.697

Current CPI (Mar. 2024) = 131.7762.

Beximco Pharmaceuticals Quarterly Data

Book Value per Share CPI Adj_Book
201309 0.292 98.790 0.389
201312 0.297 98.326 0.398
201403 0.301 99.695 0.398
201406 0.302 100.560 0.396
201409 0.308 100.428 0.404
201412 0.314 99.070 0.418
201503 0.319 99.621 0.422
201506 0.323 100.684 0.423
201509 0.329 100.392 0.432
201512 0.000 99.792 0.000
201609 0.353 101.861 0.457
201612 0.359 101.863 0.464
201703 0.367 102.862 0.470
201706 0.376 103.349 0.479
201709 0.385 104.136 0.487
201712 0.388 104.011 0.492
201803 0.397 105.290 0.497
201806 0.406 106.317 0.503
201809 0.417 106.507 0.516
201812 0.421 105.998 0.523
201903 0.432 107.251 0.531
201906 0.444 108.070 0.541
201909 0.457 108.329 0.556
201912 0.460 108.420 0.559
202003 0.474 108.902 0.574
202006 0.487 108.767 0.590
202009 0.503 109.815 0.604
202012 0.511 109.897 0.613
202103 0.533 111.754 0.628
202106 0.555 114.631 0.638
202109 0.577 115.734 0.657
202112 0.580 117.630 0.650
202203 0.596 121.301 0.647
202206 0.609 125.017 0.642
202209 0.631 125.227 0.664
202212 0.626 125.222 0.659
202303 0.640 127.348 0.662
202306 0.655 128.729 0.671
202312 0.676 129.419 0.688
202403 0.697 131.776 0.697

Add all the adjusted book value per share together and divide the count will get our Cyclically Adjusted Book per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.


Beximco Pharmaceuticals  (LSE:BXP) Cyclically Adjusted PB Ratio Explanation

Compared with the regular PB Ratio, which works poorly for cyclical businesses, the Cyclically Adjusted PB Ratio smoothed out the fluctuations of book value during business cycles. Therefore it is more accurate in reflecting the valuation of the company.

If a company has consistent business performance, the Cyclically Adjusted PB Ratio should give similar results to regular PB Ratio.


Beximco Pharmaceuticals Cyclically Adjusted PB Ratio Related Terms

Thank you for viewing the detailed overview of Beximco Pharmaceuticals's Cyclically Adjusted PB Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.


Beximco Pharmaceuticals (LSE:BXP) Business Description

Traded in Other Exchanges
Address
19 Dhanmondi, Road No. 7, Dhaka, BGD, 1205
Beximco Pharmaceuticals Ltd is engaged in manufacturing and marketing a wide range of generic pharmaceutical formulation products, life-saving intravenous fluids, therapeutic nutrition products, and Active Pharmaceutical Ingredients. It manufactures various pharmaceutical products including oral contraceptives, hormones, steroids, anti-histamine, anti-fibrinolytic, cardiac, musculoskeletal, respiratory, vitamin & mineral supplements, women's health products, and others. The products of the company are sold in domestic and international markets. Key revenue accrues from local sales.